Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    a phase iii randomized trial of pulse actinomycin-d
Show Display Options
Rank Status Study
1 Recruiting Methotrexate or Dactinomycin in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
Conditions: Gestational Trophoblastic Tumor;   Good Prognosis Metastatic Gestational Trophoblastic Tumor;   Hydatidiform Mole;   Uterine Corpus Choriocarcinoma
Interventions: Drug: Leucovorin Calcium;   Biological: Dactinomycin;   Drug: Methotrexate;   Other: Quality-of-Life Assessment

Indicates status has not been verified in more than two years